Skip to content
Resources › Clinical Evidence › Part 3 of 5

Used at home by high-risk patients

Remote nonstress tests for high-risk patients at Penn Medicine and Banner Health.

2024
Use of a wireless monitoring device to perform nonstress tests from home: the patient perspectiveHamm RF, Steele MC, O’Brien C, et al. Am J Obstet Gynecol MFM 2024;6(4):101342

Penn patients rated home NSTs acceptable; their feedback led to changes in the belt for comfort and signal.

Penn Medicine
2024
Real-world benefits of the INVU remote fetal nonstress testing platformMcLaughlin B. Am J Obstet Gynecol 2024;230(3):e22 (letter)

A Banner Health obstetrician reports a year of INVU in rural telemedicine, with better visit compliance.

Banner Health
2023
Utilization of a wireless monitoring device to perform nonstress tests in high-risk pregnancies from homeHamm RF, Shkolnik K, Keren N, et al. Am J Obstet Gynecol 2023;229(4):463–4

At Penn Medicine, patients avoided an office visit in 88.5% of remote NST appointments; 98.3% of interpretable NSTs were reactive.

Penn Medicine

The papers above, in plain language

3 summaries

We wrote short, plain-language summaries of 3 of the 3 papers on this page. Each one opens the summary, with a link to the full paper inside. In the list above, look for “Summary →”.

Keep exploring

More about INVU™ beyond the published research.

Get in touch

Interested in learning more?

Whether you would like to know more about INVU™, explore a research collaboration, or partner with us, we would love to hear from you.

Email info@nuvocares.com ↗